Core Viewpoint - Nu Skin Enterprises reported a decline in both revenue and earnings for Q1 2024, primarily impacted by foreign currency fluctuations, while managing costs effectively to support its bottom line [2][5]. Financial Performance - Adjusted earnings were 9 cents per share, down from 37 cents year-over-year, but exceeded the Zacks Consensus Estimate of 5 cents [2]. - Revenues totaled 431 million, with a negative impact of 3.8% from foreign currency [2][3]. - Gross profit decreased to 153.5 million from 124.6 million, accounting for 29.9% of revenues, up from 27.8% [4]. Regional Revenue Performance - Revenue declines were noted across various regions, with the Americas down 20.1% and Mainland China down 39.3% [4]. - Other revenues surged by 684.3% year-over-year [4]. Financial Position and Guidance - Cash and cash equivalents stood at 453.2 million and total stockholders' equity of 1.73 billion and 1.35, down from $1.85 in 2023 [7]. Estimate Trends - There has been a downward trend in consensus estimates, with a significant shift of -52.7% noted [8][10]. Industry Comparison - Nu Skin operates within the Zacks Cosmetics industry, where competitor Helen of Troy reported a slight revenue increase of 1% in its latest quarter [11].
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?